(1)
Immunotherapy for Recurrent Orthostatic Cerebral Hypo-Perfusion Syndrome in Recurrent COVID-19 Infection. Nep J Neurosci 2021, 18 (2), 64-66. https://doi.org/10.3126/njn.v18i2.35516.